BIMZELX 160 mg/ml ser pré (emb individ) 1 ml
7680685480019
CH-68548
L04AC21
07.15.0.
Reimbursement limitations:
BIMZELX.01
Psoriasis en plaque (uniquement 160 mg/ml 2 seringues/stylos prêts à l'emploi)
Traitement de patients adultes …
1 / 2
google
Details
- Product number
- 6854801
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- bimekizumabum 160 mg, glycinum, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, aqua ad iniectabile, ad solutionem pro 1.0 ml corresp., natrium 0.45 mg.
Articles (1)
Bimzelx 160 mg, solution injectable en seringue préremplie
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
160.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.45 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1058.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2024
Authorization holder
UCB-Pharma SA
1630 Bulle
Authorization information
- Swissmedic authorization number
- 68548
- Drug name
- Bimzelx, solution injectable en seringue préremplie
- Galenic form
- INLFS
- ATC Code
- L04AC21
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 27/10/2022
- Authorization expiration date
- 26/10/2027
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BIMZELX 160 mg/ml ser pré (emb individ) 1 ml
- Description (DE)
- BIMZELX 160 mg/ml Fertspr (Einzelpackung) 1 ml
- Market launch
- 27/10/2022
- Narcotic (BTM)
- No